BioXcel Therapeutics (BTAI) Q3 2025 Earnings

Aug 12Confirmed
Q4 2024
Q1 2025
Q2 2025
Q3 2025
-8.09
-5.89
-3.7
-1.5

Details

Expected EPS
-1.8575
Actual EPS
-2.45
Surprise EPS
-0.59
Surprise Percent
-31.9%

Description

⁨BioXcel Therapeutics⁩ (⁦BTAI⁩) has reported earnings of ⁦-2.45⁩ per share for ⁦Q3 2025⁩.

0 Comments

Share your thoughts